欢迎访问东方智库
会员登录 | 免费注册
讲师入驻通道
免费咨询热线:13810808675
RonMathijssen RonMathijssenstudiedmedicineattheErasmusUniversityRotterdamforwhichhereceivedhisMDdegreein2000.Twoyearslaterhedefendedhisthesis(cumlaude)entitled:‘Irinotecan:fromClinicalPharmacokineticstoPharmacogenetics’.Subsequently,hebecameInternist,MedicalOncologist,andClinicalPharmacologist.Heiscloselycollaboratingwithnationalandinternationalgroups,supervisesseveralPhDstudents,andpublishedover120peerreviewedpapers.Inaddition,heteachesstudents,reviewspapersformanyjournals,andisamemberoftheDutchCancerSocietyscientificcounsel.Finally,heischairoftheDutchPharmacologyOncologyGroup;anationalcollaborationtoindividualizethedoseofanti-cancerdrugs.Since2013,heisaprofessorinIndividualizedOncologicalPharmacotherapyattheDepartmentofMedicalOncology,headingthedivisionofTranslationalPharmacology.Hismainresearchisfocusedon‘tailoredtherapy’ofsystemicanti-canceragentsliketaxanes,tamoxifen,irinotecan,tyrosinekinaseinhibitors,andphaseIdrugs.
热点文章
-
02-18 / (4271)
-
02-29 / (2717)
联系我们
微信咨询
微信扫一扫